LATEST ARTICLES

Pharma

Rhizen Pharmaceuticals AG Announces First Patient Dosing in a Phase I/Ib Study of Its Novel PARP Inhibitor (RP12146) in Patients With Advanced Solid Tumors

Life Sciences Times - 0
Pharma

Perspectum and HepQuant Announce Partnership to Bring a More Complete Picture of Liver Health

Life Sciences Times - 0
Pharma

CANbridge Pharmaceuticals Enters into Duchenne Muscular Dystrophy Gene Therapy Research Agreement with University of Washington School of Medicine

Life Sciences Times - 0
Venture Capital

Empowering Targeted Cancer Drug Discovery with AI and Novel Disease Models, Signet Therapeutics Raises ~$10 million in Seed-2 Round

Life Sciences Times - 0
Venture Capital

Better Therapeutics Closes Business Combination and Debuts on Nasdaq

Life Sciences Times - 0
Pharma

Dr. Reddy’s Laboratories Announces the Launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market

Life Sciences Times - 0
Venture Capital

inTEST Expands Process Technology Offerings with Acquisition of Videology Imaging Solutions

Life Sciences Times - 0
Pharma

Clinical and Patient-Reported Outcomes in People Living With HIV on Biktarvy® in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting

Life Sciences Times - 0
Biotech

Despite Recent FDA Hold, US Cancer Specialists Are Enthusiastic About CAR T-Cell Therapies, Says InCrowd Instant Insights Data

Life Sciences Times - 0
Medtech

InterSystems IRIS for Health™ and First Line Software to Streamline Clinical Research Workflows on i2b2

Life Sciences Times - 0
1...707708709...832Page 708 of 832

Most Popular

Load more

Recent Comments